Skip to content

Psychedelic-assisted therapy research published in 2021

Page 2 of 3: studies 21 to 40 of 55, newest first. Back to the psychedelic-assisted therapy overview

Studies

Sleep Quality Improvements After MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder.

Journal of Traumatic Stress August 1, 2021 Linnae Ponté, Lisa Jerome, Scott Hamilton et al. 42 citations Expression of concern

Sleep disturbances (SDs) are among the most distressing and commonly reported symptoms in posttraumatic stress disorder (PTSD). Despite increased attention on sleep in clinical PTSD research, SDs remain difficult to treat. In Phase 2 trials, 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy has been shown to greatly improve PTSD symptoms. We hypothesized that MDMA-assisted...

DOI: 10.1002/jts.22696 (opens in new tab) Full text (opens in new tab) Psychedelic therapy PTSD Treatment Trauma treatment Mental health recovery +16

The phenomenology of psychedelic therapy

Philosophy of Psychedelics August 1, 2021 Chris Letheby 1 citation

‘The phenomenology of psychedelic therapy’ provides a selective overview of experiences commonly reported by those who take psychedelics in controlled and structured settings, such as clinical trials and religious rituals. The first half of this chapter reviews a variety of typical changes to perception and the sense of self. The second half reviews qualitative evidence concerning patients’...

DOI: 10.1093/med/9780198843122.003.0003 (opens in new tab) Entheogenic therapy Self-discovery Self-awareness Personal insight +4

The mechanisms of psychedelic therapy

Philosophy of Psychedelics August 1, 2021 Chris Letheby 2 citations

‘The mechanisms of psychedelic therapy’ presents arguments against three theories of psychedelic therapy. The Molecular Neuroplasticity Theory ascribes therapeutic benefits to an experience-independent molecular mechanism. This theory is undermined by the correlation between ‘mystical-type experiences’ and beneficial outcomes, which suggests that genuinely psychological mechanisms are involved....

Mystical Experience with Cancer Patients: Insights from Psychedelic-Assisted Psychotherapy and Guided Imagery

Global Journal of Medical Research July 31, 2021 Jerry B. Brown, Julie M. Brown

Background: In controlled, clinical studies of the impact of psilocybin on patients with life-threatening cancers, Johns Hopkins and NYU researchers found that the “intensity of the mystical experience” induced by psychedelic-assisted psychotherapy was directly correlated with the alleviation of cancer-related mental distress. Objective: The purpose of this article is to explore the proposition...

Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy

American Journal of Psychotherapy July 23, 2021 David Horton, Blaise Morrison, Judy A. Schmidt 92 citations

This systematized review found important commonalities among clinical trials of PAP published within the past 25 years and revealed key differences among studies in psychotherapy's incorporation into PAP. Additional research is needed to identify the unique effect of psychotherapy in PAP.

DOI: 10.1176/appi.psychotherapy.20200055 (opens in new tab) Psilocybin Psychotherapist Psycinfo Clinical trial +2

Psychedelic Therapy Hits Another Milestone, But Caution Urged

Psychiatric News July 22, 2021 Nick Zagorski

Positive findings from a phase 3 trial may have brought MDMA-assisted therapy closer to FDA approval, but experts remain unclear about how long the effects of the therapy might last. When Charles Raison, M. D. , a professor of psychiatry and the Mary Sue and Mike Shannon Chair for Healthy Minds, Children & Families at the University of Wisconsin-Madison joined the scientific board at the...

DOI: 10.1176/appi.pn.2021.7.14 (opens in new tab) Milestone Center of excellence Psychotherapist Law

Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?

Frontiers in Psychiatry July 19, 2021 Rita Kočárová, Jiřı́ Horáček, Robin Carhart-Harris 95 citations

Addressing global mental health is a major 21st-century challenge. Current treatments have recognized limitations; in this context, new ones that are prophylactic and effective across diagnostic boundaries would represent a major advance. The view that there exists a core of transdiagnostic overlap between psychiatric disorders has re-emerged in recent years, and evidence that psychedelic...

DOI: 10.3389/fpsyt.2021.661233 (opens in new tab) Neuroplasticity Context archaeology Action physics Psychotherapist +3

Current Perspective on the Therapeutic Preset for Substance-Assisted Psychotherapy

Frontiers in Psychology July 13, 2021 Sascha Thal, Stephen Bright, Jason M. Sharbanee et al. 39 citations

The present narrative review is the first in a series of reviews about the appropriate conduct in substance-assisted psychotherapy (SAPT). It outlines a current perspective onpreconditions and theoretical knowledge that have been identified as valuable in the literaturefor appropriate therapeutic conduct in SAPT. In this context, considerations regarding ethics and the spiritual emphasis of the...

DOI: 10.3389/fpsyg.2021.617224 (opens in new tab) Context archaeology Psychotherapist Perspective graphical Therapeutic relationship +1

Palliative care: is it time for health professionals to talk openly about psychedelic therapy?

British Journal of General Practice June 24, 2021 Emma Presern 1 citation

I’ve always been drawn to specialties where medicine can be practised holistically. It’s one of the reasons I applied for GP training and am currently undertaking a diploma in lifestyle medicine. My last post as a second-year GP trainee was a 6-month placement in palliative medicine at a well-known inner London hospice. While on this rotation, I came across patients who suffered with ‘total...

DOI: 10.3399/bjgp21x716333 (opens in new tab) Full text (opens in new tab) Distress Palliative care Mental health Existentialism +5

Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders

Canadian Journal of Health Technologies June 24, 2021 Yi‐sheng Chao, Jennifer Horton 5 citations

Two systematic reviews, 3 randomized controlled trials, and 2 single-arm safety trials were identified that evaluated several combinations of psychedelic-assisted psychotherapy. Psilocybin was the psychedelic most tested. Other psychedelics identified in the systematic reviews and primary studies were 3,4-methylenedioxymethamphetamine (or MDMA), lysergic acid diethylamide (or LSD), ayahuasca...

Scaling Up: Multisite Open-Label Clinical Trials of MDMA-Assisted Therapy for Severe Posttraumatic Stress Disorder

Journal of Humanistic Psychology June 23, 2021 Julie B. Wang, Jessica Lin, Leah Bedrosian et al. 22 citations

Background: Posttraumatic stress disorder (PTSD) is a debilitating mental health condition associated with serious adverse health outcomes and functional impairment. Previous MDMA–assisted therapy (MDMA-AT) studies have shown promising results in single site studies. Two open-label studies tested this modality in multisite clinical trials to assess the feasibility of scaling this manualized...

DOI: 10.1177/00221678211023663 (opens in new tab) Psychedelic therapy PTSD Treatment Trauma therapy Mental health treatment +15

Music's essential role during psychedelic therapy

June 1, 2021 Alexander Jeffrey Kahn, Florence Ierardi

Music is an essential component of psychedelic therapy. Music can help to structure the experience, elicit emotion, facilitate meaning-making, stimulate imagery, provide continuity, support peak experiences, and more. Clients who have positive experiences with music often demonstrate higher therapeutic outcomes during psychedelic therapy. Although music is ubiquitous during psychedelic therapy,...

DOI: 10.17918/00001535 (opens in new tab) Music therapy Visual arts Psychoanalysis Psychotherapist

Psychedelic-Assisted Psychotherapy

Cambridge University Press eBooks May 28, 2021 Tim Read 2 citations

In recent years there has been a resumption of research into the potential therapeutic benefits of psychedelic1 drugs such as MDMA2, psilocybin and LSD3. Clinical research suggests significant efficacy for psychiatric disorders that have traditionally been hard to treat. The evidence base has accumulated to the point that psychedelic-assisted psychotherapy appears to be moving from a fringe...

DOI: 10.1017/9781108686976.030 (opens in new tab) Psilocybin Psychotherapist Subject documents Hallucinogen +1

Psychedelic‐assisted therapy considered ‘breakthrough’ treatment for PTSD

Mental Health Weekly May 17, 2021 Valerie A. Canady 1 citation

New research involving the use of psychedelic‐assisted therapy is showing promise and significant implications for patients with severe, chronic post‐traumatic stress disorder (PTSD) and could potentially move the needle further toward Food and Drug Administration (FDA) approval, say researchers from the Multidisciplinary Association for Psychedelic Studies (MAPS).

DOI: 10.1002/mhw.32791 (opens in new tab) Psychedelic therapy PTSD Treatment Trauma therapy Chronic PTSD Relief +14

CE: Psychedelic-Assisted Therapy

AJN, American Journal of Nursing May 16, 2021 Andrew Penn, Caroline Dorsen, Stephanie Hope et al. 40 citations

Psychedelics are a class of psychoactive substances that were studied extensively between 1943 and 1970 as potential therapies for treating a host of mental health disorders, including addiction. Despite promising early results, U.S. psychedelic research was halted in the early 1970s with the enactment of the Controlled Substances Act. As the field of psychedelic-assisted therapy develops,...

Psychedelic Therapy: Diplomatic Re-compositions of Life/Non-life, the Living and the Dead

The Movement for Global Mental Health April 23, 2021 Harish Naraindas 1 citation

This chapter, which is an ethnography of a psychosomatic department in a German hospital, functions as a foil to the rest of the volume. It allows us to ask the following: Why is the movement for global mental health preoccupied with the Global South? Why does mental health in the Global South primarily revolve around the psycho-pharmaceutical, while psychosomatic medicine, which in the German...

Psychedelic-Assisted Psychotherapy Practices and Human Caring Science: Toward a Care-Informed Model of Treatment

Journal of Humanistic Psychology April 23, 2021 Andrew Penn, Janis Phelps, William E Rosa et al. 37 citations

Psychedelic therapies intentionally combine a caring/healing environment, psychotherapy, and psychedelic medicine as a powerful means of treating intractable conditions of depression and posttraumatic stress disorder. This article utilizes the nursing theory of human caring science, as articulated by Jean Watson, to describe the essential and fundamental human caring qualities in psychedelic...

DOI: 10.1177/00221678211011013 (opens in new tab) Psilocybin Psychotherapist Watson Openness to experience +1

Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?

Journal of Psychopharmacology April 22, 2021 Robin Carhart-Harris, Anne C Wagner, Manish Agrawal et al. 54 citations

Favourable regulatory assessments, liberal policy changes, new research centres and substantial commercial investment signal that psychedelic therapy is making a major comeback. Positive findings from modern trials are catalysing developments, but it is questionable whether current confirmatory trials are sufficient for advancing our understanding of safety and best practice. Here we suggest...

DOI: 10.1177/02698811211008567 (opens in new tab) Full text (opens in new tab) Psychedelic therapy Psychedelic medicine Innovative treatments Psychopharmacology +20

Mapping an Agenda for Psychedelic-Assisted Therapy Research in Patients with Serious Illness.

Journal of Palliative Medicine April 13, 2021 Yvan Beaussant, James A. Tulsky, Benjamin Guérin et al. 34 citations

Background: With support from the Radcliffe Institute for Advanced Study at Harvard University, we convened researchers representing palliative care, psychosocial oncology, spiritual care, oncology, and psychedelic-assisted therapies. We aimed to define priorities and envision an agenda for future research on psychedelic-assisted therapies in patients with serious illness. Over two days in...

DOI: 10.1089/jpm.2020.0764 (opens in new tab) Full text (opens in new tab) Psychedelic medicine Hallucinogen therapy Mental health: well-being Psychological health +8